Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

22 Sep, 2017, 08:20 BST Natera Selected for Circulating Tumor DNA Study in Bladder Cancer

Denmark's Aarhus University to Use Signatera™ ctDNA Technology in Longitudinal Study Natera, Inc., (NASDAQ: NTRA), a global leader in...


21 Sep, 2017, 07:59 BST Alligator Bioscience to Present ADC-1013 Intratumoral Clinical Phase I Study Results at SITC in November 2017

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


20 Sep, 2017, 18:00 BST deCODE Study Reveals an Ancient Achilles Heel in the Human Genome

- The generation of new mutations is a key driver of evolution but also of susceptibility to rare diseases - Fathers pass on...


20 Sep, 2017, 13:00 BST Norgine Launches LYMPHOSEEK®▼ (99mTc-tilmanocept) in Italy

Norgine B.V. today announced the launch of LYMPHOSEEK® (technetium Tc 99m tilmanocept) in Italy. LYMPHOSEEK® is a radiopharmaceutical used for...


20 Sep, 2017, 11:49 BST Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

Edinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it has...


20 Sep, 2017, 08:30 BST PharmaMar Starts Clinical Studies with a New Compound -PM14- in Patients with Solid Tumors

With the motivation of finding a solution to the unmet needs of patients with different types of cancer, PharmaMar (MCE: PHM) announces the start...


19 Sep, 2017, 16:00 BST Oxitec to Build State-of-the-Art Mosquito Egg Production Unit

UK Prime Minister Theresa May Announces UK facility with Capacity to Generate One Billion Friendly™ Aedes Mosquito Eggs per Week Oxitec Ltd, a...


19 Sep, 2017, 13:00 BST BERG Broadens Relationship With The Department Of Defense (DoD) Center For Prostate Disease Research With New Predictive Biomarker Test For Prostate Cancer

New Clinical Evidence Guided by Artificial Intelligence that Could Significantly Enhance Prostate Cancer Detection and Reduce Over-Diagnosis and...


19 Sep, 2017, 12:03 BST Sepsis Power Hour Solution Accelerates Care, Reduces Costly Treatment Measures

Sepsis is the primary cause of death from infection worldwide, with over 18 million cases per year, and represents the most costly condition...


19 Sep, 2017, 10:24 BST Indivumed and Helomics Partner to Unlock the Power of Cancer Biospecimens for Drug Discovery and Development

Indivumed GmbH (Indivumed) and Helomics® Corporation (Helomics) announce their intentions to collaborate to analyze human cancer biospecimens and...


19 Sep, 2017, 09:33 BST Rapid Medical: First Patient Enrolled in the TIGERTRIEVER Acute Ischemic Stroke Registry

- The post marketing registry will assess the real-life safety and performance of the TIGERTRIEVER revascularization device Today, Rapid Medical,...


19 Sep, 2017, 06:00 BST Anecova: First Babies Born in Poland with AneVivo Natural Fertilisation

After starting the commercialisation of AneVivo, its first assisted reproductive technology device, Anecova is proud to announce a major...


18 Sep, 2017, 17:44 BST TSI Completes Phase 1 Clinical Trial of Novel Clot-dissolving Therapy, TS01

Novel Mechanism of Action Promotes Enhanced Safety and Efficacy for the Treatment of Stroke and Myocardial Infarction Thrombolytic Science,...


18 Sep, 2017, 16:29 BST $5.8 Million Awarded For Vaccine Engineering Will Use "Immune History" To Protect Against Bird Flu, A Collaboration Led By EpiVax

EpiVax, Inc. ("EpiVax") a pioneer in the fields of bioinformatics and immune engineering, today announced a new NIH-funded collaboration to develop...


18 Sep, 2017, 15:39 BST Institut Marquès presents their studies on music and the beginning of life at the Massachusetts Institute of Technology

- Dr. Marisa López-Teijón, director of this internationally renowned center in Assisted Reproduction, has received the Ig Nobel Prize for...


18 Sep, 2017, 11:30 BST Real-World Data Confirms Long-Term Effectiveness Of Bronchial Thermoplasty

Patients with Severe Asthma Show Sustained Clinical Improvement Boston Scientific (NYSE: BSX) today announced results from a three year...


18 Sep, 2017, 08:00 BST MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish Between Bacterial and Viral Infections

MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish...


18 Sep, 2017, 07:15 BST Merck Announces Recipients of the Grant for Growth Innovation 2017

- The presentation of the grants coincides with the 10th International Meeting of Pediatric Endocrinology - The awards program...


16 Sep, 2017, 12:56 BST Galderma: 'Clear' (IGA 0) Rosacea Patients Experience a Delayed Time to Relapse

Today, the results of a pooled analysis of four Galderma-sponsored studies evaluating the use of topical therapies for the treatment of...


15 Sep, 2017, 08:31 BST Tresiba® Trial Shows that People with Type 2 Diabetes who Avoid Severe Hypoglycaemia have a Reduced Risk of Death

Symposium: S33 Novo Nordisk today announced new analyses from the multinational, double-blinded DEVOTE trial showing that people with type 2...


14 Sep, 2017, 20:42 BST Efficacy of Philips' Stellarex .035" low-dose drug-coated balloon demonstrated in clinical trial at two years

- Two-year data from the ILLUMENATE European randomized clinical trial (EU RCT) validates durable clinical performance of Stellarex low-dose...


14 Sep, 2017, 13:29 BST ISA: Low Calorie Sweeteners Don't Affect Glucose Control nor Increase Diabetes Risk

Study findings presented at EASD annual meeting by Young et al. are not supported by a number of earlier studies by the same research group In...


13 Sep, 2017, 15:31 BST Xultophy® Reduces Cardiovascular Risk Factors in People with Type 2 Diabetes

Oral Presentation 113 In people with type 2 diabetes, Xultophy® (insulin degludec/liraglutide) significantly reduced a number of risk factors...


13 Sep, 2017, 14:00 BST Ascensia Diabetes Care Launches Global Innovation Competition to Find Digital Solutions to Help Tackle the Epidemic of Type 2 Diabetes

Today, during the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Ascensia Diabetes Care announced the launch of...


13 Sep, 2017, 07:46 BST Alligator Bioscience Signs Immunotherapy Research Collaboration Agreement for 4-1BB

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed...


Most Viewed Clinical Trials & Medical Discoveries